| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
|
J Hepatol
|
2010
|
2.11
|
|
2
|
Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.
|
J Gastroenterol Hepatol
|
2010
|
1.79
|
|
3
|
Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review.
|
Eur J Gastroenterol Hepatol
|
2013
|
1.49
|
|
4
|
Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
|
Hepatology
|
2013
|
1.39
|
|
5
|
Two hypotheses for decreasing hepatic encephalopathy risk after transjugular intrahepatic portosystemic shunt.
|
Hepatology
|
2010
|
1.39
|
|
6
|
Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
|
Hepatology
|
2014
|
1.27
|
|
7
|
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center.
|
Radiology
|
2012
|
1.12
|
|
8
|
Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.
|
J Gastroenterol Hepatol
|
2011
|
1.00
|
|
9
|
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.
|
Medicine (Baltimore)
|
2016
|
0.90
|
|
10
|
A systematic review and meta-analysis of randomized trials and prospective studies comparing covered and bare self-expandable metal stents for the treatment of malignant obstruction in the digestive tract.
|
Int J Med Sci
|
2013
|
0.90
|
|
11
|
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
|
Thromb Haemost
|
2015
|
0.90
|
|
12
|
Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis.
|
Medicine (Baltimore)
|
2015
|
0.90
|
|
13
|
Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review.
|
Asia Pac J Clin Oncol
|
2013
|
0.89
|
|
14
|
Stage of portal vein thrombosis.
|
J Hepatol
|
2010
|
0.88
|
|
15
|
Degree of portal vein thrombosis.
|
Hepatology
|
2010
|
0.87
|
|
16
|
Anticoagulation for portal vein thrombosis in cirrhosis.
|
Am J Med
|
2010
|
0.87
|
|
17
|
Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis.
|
Thromb Res
|
2012
|
0.84
|
|
18
|
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis.
|
Hepatol Res
|
2013
|
0.83
|
|
19
|
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center.
|
Cardiovasc Intervent Radiol
|
2014
|
0.82
|
|
20
|
The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt?
|
Hepatology
|
2010
|
0.81
|
|
21
|
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
|
J Gastroenterol Hepatol
|
2014
|
0.81
|
|
22
|
Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS.
|
PLoS One
|
2013
|
0.80
|
|
23
|
l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.
|
J Gastroenterol Hepatol
|
2013
|
0.79
|
|
24
|
Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: a systematic review and meta-analysis.
|
Curr Stem Cell Res Ther
|
2015
|
0.79
|
|
25
|
Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
|
Eur J Gastroenterol Hepatol
|
2016
|
0.79
|
|
26
|
Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma.
|
Hepatology
|
2012
|
0.79
|
|
27
|
Studies on immunoregulatory and anti-tumor activities of a polysaccharide from Salvia miltiorrhiza Bunge.
|
Carbohydr Polym
|
2012
|
0.78
|
|
28
|
Hepatocellular carcinoma.
|
Lancet
|
2012
|
0.78
|
|
29
|
Diagnostic accuracy of data on aspartate aminotransferase to platelets index might be false in the paper by Tafarel et al.
|
Eur J Gastroenterol Hepatol
|
2015
|
0.77
|
|
30
|
Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures.
|
Medicine (Baltimore)
|
2015
|
0.77
|
|
31
|
Degree of portal vein thrombosis might be associated with recanalization during anticoagulation.
|
Clin Gastroenterol Hepatol
|
2012
|
0.77
|
|
32
|
Lack of association between TNF-α gene promoter polymorphisms and pancreatitis: a meta-analysis.
|
Gene
|
2012
|
0.77
|
|
33
|
Directions of odds ratios might be inappropriate in the paper by Tafarel et al.
|
Eur J Gastroenterol Hepatol
|
2015
|
0.77
|
|
34
|
Portal vein thrombosis significantly improves the survival of cirrhotic patients awaiting liver transplantation: should we accept the statistical results?
|
Eur J Intern Med
|
2015
|
0.75
|
|
35
|
Prevalence of hepatocellular carcinoma in Chinese Budd-Chiari syndrome patients: an extended systematic review using Chinese-language databases.
|
Eur J Gastroenterol Hepatol
|
2013
|
0.75
|
|
36
|
Anticoagulation and variceal bleeding in non-cirrhotic patients with portal vein thrombosis.
|
Intern Emerg Med
|
2010
|
0.75
|
|
37
|
Coagulopathy of chronic liver disease.
|
N Engl J Med
|
2011
|
0.75
|
|
38
|
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis.
|
Gut
|
2011
|
0.75
|
|
39
|
Spontaneous resolution of portal vein thrombosis in cirrhosis: where do we stand, and where will we go?
|
Saudi J Gastroenterol
|
2014
|
0.75
|
|
40
|
Nonmalignant partial portal vein thrombosis in liver cirrhosis: to treat or not to treat?
|
Radiology
|
2013
|
0.75
|
|
41
|
A confusing relationship between Child-Turcotte-Pugh class A and compensated cirrhosis.
|
Am J Gastroenterol
|
2010
|
0.75
|
|
42
|
Which journal published more randomized controlled trials in the field of cirrhosis and portal hypertension?
|
Liver Int
|
2012
|
0.75
|
|
43
|
Large paraesophageal varices causing recurrent hepatic encephalopathy.
|
Am J Med Sci
|
2014
|
0.75
|
|
44
|
Complete remission of hepatocellular carcinoma after transarterial Chemoembolization combined with brivanib.
|
J Cancer Res Ther
|
2015
|
0.75
|
|
45
|
Thrombopoietin receptor agonists significantly increase the risk of portal vein thrombosis in liver diseases: Meta-analysis of RCTs.
|
Thromb Haemost
|
2015
|
0.75
|
|
46
|
Albumin-bilirubin, Child-Pugh, and model for end-stage liver disease scores for the assessment of prognosis in cirrhotic patients.
|
Turk J Gastroenterol
|
2017
|
0.75
|
|
47
|
Education and Imaging. Hepatobiliary and pancreatic: inferior mesenteric vein-left gonadal vein shunt aggravating hepatic encephalopathy.
|
J Gastroenterol Hepatol
|
2012
|
0.75
|
|
48
|
Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study.
|
Turk J Gastroenterol
|
2016
|
0.75
|